Global Cord Blood Co. (NYSE:CO - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.40 and traded as high as $1.50. Global Cord Blood shares last traded at $1.50, with a volume of 14,458 shares.
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on shares of Global Cord Blood in a research report on Tuesday. They set a "strong-buy" rating on the stock.
Check Out Our Latest Analysis on CO
Global Cord Blood Trading Up 42.9 %
The stock's 50 day moving average is $1.32 and its 200-day moving average is $1.40. The company has a market cap of $182.33 million, a P/E ratio of 2.34 and a beta of 0.16.
About Global Cord Blood
(
Get Free Report)
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.
Featured Articles
Before you consider Global Cord Blood, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Cord Blood wasn't on the list.
While Global Cord Blood currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
